Skip to content
Products
Resources
Company
Virtual lab
Keep in contact
Solid tumor
Blood cancer
Pharmacogenetics
Knowledge hub
Publications
About us
Virtual lab
Careers
Press hub
Contacts
Products
+
Solid tumor
Blood cancer
Pharmacogenetics
Resources
+
Knowledge hub
Publications
Company
+
About us
Virtual lab
Careers
Press hub
Contacts
Virtual lab
Keep in contact
Reserved Area
Publications
Publications
Scientific contributions highlighting the impact of Diatech Pharmacogenetics technologies in diagnostics.
Filter
Year
All years
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2008
Product line
All product lines
Easy
Easy PGX
Helix
Microsatelliti
Myriapod
Myriapod NGS
Realquant
Response
13.07.2021
Microsatelliti
Intratumor morphologic and transcriptomic heterogeneity in V600EBRAF-mutated metastatic colorectal adenocarcinomas
01.07.2021
Easy PGX
Perfect concordance between blood-based and normal tissue-based dihydropyrimidine dehydrogenase polymorphisms suggests that pharmacogenetic screening could be contextual to tumour molecular profiling
30.06.2021
Easy
COVID-19 autopsy cases: detection of virus in endocrine tissues
24.06.2021
Response
H3K27me3 immunostaining is diagnostic and prognostic in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphology
15.06.2021
Response
Serum Exosomal microRNA-21, 222 and 124-3p as Noninvasive Predictive Biomarkers in Newly Diagnosed High-Grade Gliomas: A Prospective Study
18.05.2021
Helix
EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience.
14.05.2021
Easy
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines.
10.05.2021
Response
High BRAF variant allele frequencies are associated with distinct pathological features and responsiveness to target therapy in melanoma patients.
17.04.2021
Response
Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas
16.04.2021
Easy PGX
Combination of ultrasound and molecular testing in malignancy risk estimate of Bethesda category IV thyroid nodules: results from a single-institution prospective study
Previous
Page
1
…
Page
18
Page
19
Page
20
Page
21
Page
22
…
Page
46
Next
Subscribe to Our Newsletter
First name
Last name
Company / Istitution
Country
Email
I confirm that I have read the
information on the personal data management.
I agree to the processing of my personal data according to the above mentioned information
Subscribe
Search
Search